Millenco reduces stake in Orchid Cellmark to 7.3%

By Angela McDaniels

Tacoma, Wash., March 13 - Orchid Cellmark Inc. investors led by Millenco LLC sold 335,100 shares of the company's stock on March 11 for $2.93 to $3.02 each.

The sales were reported in a schedule 13D filing with the Securities and Exchange Commission.

The investors now own 2,190,00 shares, or 7.3%, of the company's common stock.

Orchid Cellmark, located in Princeton, N.J., provides DNA testing services for the human identity and agricultural sectors.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.